1. Home
  2. LUNG vs NUW Comparison

LUNG vs NUW Comparison

Compare LUNG & NUW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • NUW
  • Stock Information
  • Founded
  • LUNG 1995
  • NUW 2008
  • Country
  • LUNG United States
  • NUW United States
  • Employees
  • LUNG N/A
  • NUW N/A
  • Industry
  • LUNG Industrial Specialties
  • NUW Investment Managers
  • Sector
  • LUNG Health Care
  • NUW Finance
  • Exchange
  • LUNG Nasdaq
  • NUW Nasdaq
  • Market Cap
  • LUNG 248.0M
  • NUW 256.2M
  • IPO Year
  • LUNG 2020
  • NUW N/A
  • Fundamental
  • Price
  • LUNG $6.67
  • NUW $14.28
  • Analyst Decision
  • LUNG Strong Buy
  • NUW
  • Analyst Count
  • LUNG 7
  • NUW 0
  • Target Price
  • LUNG $13.71
  • NUW N/A
  • AVG Volume (30 Days)
  • LUNG 213.2K
  • NUW 45.3K
  • Earning Date
  • LUNG 10-28-2024
  • NUW 01-01-0001
  • Dividend Yield
  • LUNG N/A
  • NUW 3.66%
  • EPS Growth
  • LUNG N/A
  • NUW N/A
  • EPS
  • LUNG N/A
  • NUW N/A
  • Revenue
  • LUNG $76,583,000.00
  • NUW N/A
  • Revenue This Year
  • LUNG $22.73
  • NUW N/A
  • Revenue Next Year
  • LUNG $19.02
  • NUW N/A
  • P/E Ratio
  • LUNG N/A
  • NUW N/A
  • Revenue Growth
  • LUNG 26.26
  • NUW N/A
  • 52 Week Low
  • LUNG $5.46
  • NUW $12.45
  • 52 Week High
  • LUNG $14.84
  • NUW $14.44
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 37.51
  • NUW 57.71
  • Support Level
  • LUNG $6.39
  • NUW $14.22
  • Resistance Level
  • LUNG $7.47
  • NUW $14.38
  • Average True Range (ATR)
  • LUNG 0.36
  • NUW 0.09
  • MACD
  • LUNG -0.20
  • NUW -0.01
  • Stochastic Oscillator
  • LUNG 12.93
  • NUW 62.96

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About NUW Nuveen AMT-Free Municipal Value Fund

Nuveen AMT-Free Municipal Value Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax by investing in a portfolio of municipal obligations. The fund predominantly invests in long-term municipal bonds, corporate bonds, short-term municipal bonds, and other assets.

Share on Social Networks: